# Novartis to Buy Myricx Bio for Up to $1.5 Billion

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-06 15:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Executive Summary
Novartis is expanding its cancer-drug pipeline through the acquisition of U.K.-based biotech firm Myricx Bio in a deal valued up to $1.5 billion.

## Intelligence Brief
Novartis has agreed to acquire Myricx Bio, a cancer biotech company based in the United Kingdom. The deal is valued at up to $1.5 billion, with Fierce Biotech reporting an upfront payment of $1.1 billion.


Coverage from Bloomberg, the Wall Street Journal, and the Financial Times emphasizes the deal's total valuation. Quartz and Business Wire identify the target as a U.K. biotech, while Fierce Biotech specifies that the move is intended to expand Novartis's antibody-drug conjugate (ADC) pipeline.


Further developments will likely focus on the integration of Myricx Bio into Novartis's oncology operations and the progression of the ADC pipeline.

## Verified Facts & Key Claims
### How much is Novartis paying for Myricx Bio?
The deal is valued at up to $1.5 billion, with $1.1 billion being paid upfront.

### What is the primary goal of this acquisition?
According to Fierce Biotech, Novartis intends to use the acquisition to expand its ADC pipeline.

### Where is Myricx Bio located?
Myricx Bio is a biotechnology firm based in the United Kingdom.

## Key People, Organizations & Locations
Billion, Novartis, Buy Myricx Bio for Up, Sofinnova Partners Announces Myricx Bio Agrees, Be Acquired, Myricx Bio, Myricx, ADC

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| STAT | Four major biotech updates to catch up on | 2026-07-06 08:50 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxPeWRIdUVkWHNZSDlfcXFRUENzMm5GM2NvZGx5cnlpYXdteGN4Y1hJbFRaNHhrZHBDcFJUT1FSNENBd2ZiNlc3RHFDM2dKRGFQdHJTYklXcWlHVld1T0lJOVhrRGo1MnE1bnNqWGpiMmNPLVViQnBMSjBSVWpGSHd4bGc0V2h1WmVRbUlXNGowOXVXcmJlZWFZa0J3cnZOdw?oc=5) |
| qz.com | Novartis acquires U.K. cancer biotech Myricx Bio for $1.5 billion | 2026-07-06 08:50 | [Source Link](https://news.google.com/rss/articles/CBMifkFVX3lxTFA3TDdPMUtwdFJ5a29SM3lCVVhmZWV0NnBHZXY4Yk1Xa0JvNVo1S1ZGenlrZTBEZTdIVmdkWTVMTlcxTzBGV2dfaGFTdFAwODd6MlZROElRbzBkU3lZQTZVUFNVS2RqYmF0MnF6LXNsRDZ2Q0FVcFZpX0hXT05Ndw?oc=5) |
| Business Wire | Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis | 2026-07-06 08:50 | [Source Link](https://news.google.com/rss/articles/CBMiygFBVV95cUxNUkZIdERNc3dRYUpTZXgyWTdRWWw1LWxsUlNRbFl5MDhoNzhTUTVoNmZaMGNCSXF5YTc3NUxZM1dlVllqUzZZM0pwdEFkelhFLXZZUGIyRHpjWTVWeXNacEJYbGJoN1Z0MUdYb1kwcmVxWGhCbW85NGhZU3J4OWJCSVZ2S0tQR3g3clpPSDNrUG9RS2REOXFwOElOYjBSeUItRnpjd3ZvX3BVRTFDZHdjY3hzQWc3ZFlEbXhrSFBiU29zcW9yc0NCcmZ3?oc=5) |
| Financial Times | Novartis to buy UK biotech Myricx Bio in $1.5bn deal | 2026-07-06 08:50 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxPY25OMHBFeW81cWRkV1F0bFZOblYxYXNuZ210alloNHBuNmJucG16eUg1YVFqY0g3UENwXzU5Q0U4SGhiZGtCcWVBS2xGTElDSGw4UWszWjBJbW9OVjRIWENYdS1aWlBCdldCZTg2a1ZacXpTVXhrVGJGRUJ2Nk9ZSHdQQmc?oc=5) |
| Fierce Biotech | Novartis to pay $1.1B upfront for Myricx to expand ADC pipeline | 2026-07-06 08:50 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxQTTRnaTlhU0xZRE5GbWhlRWEyM0UzWjJCYVp6US1CMUNkWUxIQ1ExZ1JwYzhCOXplVTRPbHZTQkF3ZVB6ZExiSFdVZzZadGYyTVVyTEpHYy16LTV4ZGh6VWlic2VyWjc4Y2hmS05wM1ZDUWZTRlZhQmh2d01Lamkzd2RzaDFMc3dmQUtmaDgtWEFNTWs?oc=5) |
| Bloomberg.com | Novartis to Buy Cancer-Drug Firm Myricx for Up to $1.5 Billion | 2026-07-06 08:50 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxOZGwwYTBwdkhKSk82NjFRX002cHg2VXNkeFpyRTdBZmFSYjRoUzJGeE03azFQWEJGdHg3R0g0cGEtR1YyTFNSdlFUZ05jY2ZrcEVDZDlQWGlhWmMwV04waXE1QU4wQUdSa1c2OHZHVnRRQ3ZvenFBT2hmal92SlR4a1V5cVBSV054dmNDdncySGU3ZlUtaW1FeTh0bFdNRnVrdnlpOU9XZFJMSHFoU0tlOXhB?oc=5) |
| WSJ | Novartis to Buy Myricx Bio for Up to $1.5 Billion | 2026-07-06 08:50 | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxPYVp5blhhT053anh4dzVuMlhqY3ZBMlhPVDJvR080OXB4OFdJNWhORlVhQ3VpZzBSMnJoajNKS3NpWjlHQ0ZPRVBCOHBoZ1JfMURXUGIzZTFsa1h0Sm9yTWNvN3U1c0FDOU93NGhDa2t0Q0Y1QkRneWpwQ1FMcmFiSHFUbmhpSmxYclZ0RDBMUTM1ai1zQ3c?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-06/novartis-to-buy-myricx-bio-for-up-to-1-5-billion*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*